USNA - NYSE

USANA Health Sciences, Inc.

USNA·NYSE

$17.46

-3.3%

Consumer DefensivePackaged Foods

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$322.36M

EPS0.5800

P/E Ratio30.10

Earnings Date07/28/2026

742.91M

Assets

-1%

3Y+25.0%

5Y+16.0%

10Y+58.0%

156.64M

Total Liabilities

-3%

3Y-3.0%

5Y-21.0%

10Y+8.0%

586.27M

Total Equity

3Y+35.0%

5Y+33.0%

10Y+80.0%

USANA Health Sciences, Inc. Funding & Solvency Profile

USNA · NYSE

Current Assets

Cash & Cash Equivalents158.38M

Net Receivables0.00

Inventory102.61M

Other Current Assets27.42M

Total Current Assets288 M

Non-Current Assets

Property, Plant & Equipment94.38M

Goodwill & Intangible Assets271.11M

Long-Term Investments0.00

Other Non-Current Assets61.80M

Total Non-Current Assets156 M

Total Assets

742.91M

Financial Health Analysis

Current Ratio

2.24x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.27x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

160 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

39% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

USANA Health Sciences, Inc. Balance Sheet

USNA • NYSE

USANA Health Sciences, Inc. Balance Sheet	Jan 2026	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	158.4M	181.8M	330.4M	288.4M	239.8M	312.9M	234.8M	214.3M	247.1M	175.8M	143.2M	111.1M	137.3M	70.8M	50.4M	24.2M	13.7M	13.3M	12.9M	27M
Short-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.5M	0.0	0.0	0.0	0.0	8.6M	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cash & Short-Term Investments	158.4M	181.8M	330.4M	288.4M	239.8M	312.9M	234.8M	277.9M	247.1M	175.8M	143.2M	111.1M	146M	70.8M	50.4M	24.2M	13.7M	13.3M	12.9M	27M
Net Receivables	0.0	8.2M	7.2M	7.2M	7.2M	7.4M	8.8M	14M	13.5M	17M	11.8M	12.9M	13.6M	8.2M	5.7M	11.7M	6M	3.2M	6.9M	5.1M
Accounts Receivables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3M	3.7M	2.8M	3.2M	0.0	0.0
Other Receivables	0.0	8.2M	7.2M	7.2M	7.2M	7.4M	6.7M	7.6M	4.8M	4.3M	4.7M	12.9M	7M	3.4M	3M	0.0	0.0	0.0	6.9M	5.1M
Inventory	102.6M	69.7M	61.5M	67.1M	98.3M	90.2M	68.9M	81.9M	62.9M	64.8M	66.1M	45.2M	47.2M	36.5M	37M	34.1M	25.8M	23.9M	19.4M	22.5M
Prepaids	0.0	13.8M	11.4M	11.4M	13.9M	8.7M	10.2M	9.3M	8.3M	9.2M	5.6M	4.6M	5.5M	4.6M	4.5M	3.8M	3.4M	2.9M	2.9M	2.2M
Other Current Assets	27.4M	5.7M	7.3M	7.1M	3.7M	4M	6.6M	9.2M	8.3M	11M	17.6M	17.1M	16.7M	12.4M	4.6M	3.5M	3.1M	5.7M	3.9M	3.9M
Total Current Assets	288.4M	279.2M	417.7M	381.2M	362.8M	423.2M	329.3M	392.3M	340.2M	277.9M	244.3M	190.9M	229M	132.5M	106.1M	80.3M	51.9M	52.7M	46M	60.6M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	94.4M	94.6M	99.8M	117.8M	125.6M	128.4M	95.2M	92M	102.8M	101.3M	88M	71.2M	59.2M	61.8M	60.8M	57.6M	57.2M	56.8M	52.1M	30.3M
Goodwill	138M	144.2M	17.1M	17.4M	17.7M	17.4M	16.6M	16.8M	17.4M	16.7M	17.4M	17.9M	18.2M	17.9M	17.7M	16.9M	5.7M	5.7M	5.7M	5.7M
Intangible Assets	133.2M	151.8M	29.9M	32.4M	30.4M	30.8M	29.8M	31.8M	35.2M	34.3M	38.3M	41M	42.3M	42.1M	42.6M	40.6M	0.0	0.0	0.0	0.0
Goodwill & Intangible Assets	271.1M	296M	47M	49.8M	48.1M	48.2M	46.5M	48.6M	52.6M	51.1M	55.7M	58.9M	60.6M	60M	60.4M	57.5M	5.7M	5.7M	5.7M	5.7M
Long-Term Investments	0.0	2.7M	2.8M	2.9M	23.8M	3.1M	2.9M	2.9M	9.8M	9.7M	11.4M	0.0	0.0	0.0	0.0	-1.7M	-2.1M	-2.9M	-2M	-2.2M
Tax Assets	27.2M	19.6M	13.3M	9.8M	4.8M	4.6M	3.1M	3.3M	2.9M	18.3M	9.8M	5.9M	5.5M	6M	11M	1.7M	2.1M	2.9M	2M	2.2M
Other Non-Current Assets	61.8M	56.1M	52.1M	35.1M	12.6M	33.4M	40M	15.2M	11M	12.4M	14M	23.7M	14.2M	7.1M	6.3M	49M	8.6M	7.4M	5.4M	3.4M
Total Non-Current Assets	454.5M	469M	215M	215.3M	214.9M	217.7M	187.7M	162.1M	179.1M	192.8M	179M	159.7M	139.4M	134.8M	138.4M	123.5M	71.5M	69.9M	63.1M	39.4M
Total Assets	742.9M	748.2M	632.8M	596.5M	577.7M	640.9M	516.9M	554.5M	519.3M	470.6M	423.2M	350.6M	368.5M	267.4M	244.5M	203.8M	123.4M	122.6M	109.1M	100M
LIABILITIES
CURRENT LIABILITIES
Total Payables	17.3M	23.7M	13.4M	16M	18.7M	26M	18.8M	9.9M	24.1M	14.7M	20M	17.2M	19.5M	13M	13M	8M	6.1M	13.1M	10.2M	13.3M
Accounts Payable	17.3M	12M	10.1M	11M	13.5M	18.2M	12.5M	9.9M	11.8M	9M	10M	7.8M	9.5M	7M	8M	6.4M	5.8M	6.9M	8.1M	10.2M
Other Payables	0.0	11.8M	3.3M	5M	5.2M	7.8M	6.3M	0.0	12.3M	5.7M	10M	9.4M	10M	6M	5.1M	1.6M	284K	6.2M	4.2M	6.2M
Accrued Expenses	0.0	79.6M	9.8M	17.3M	32.4M	32.2M	26.2M	103.1M	71.4M	78.6M	66.1M	52.7M	19.5M	0.0	24.6M	14.4M	8.5M	11.2M	10.1M	13.5M
Short Term Debt	14M	23M	786K	6.9M	7.1M	8.6M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Capital Lease Obligations (Current)	0.0	6M	7.3M	0.0	0.0	0.0	8.3M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	0.0	11.8M	12.5M	5M	5.2M	7.8M	16.5M	20.8M	23.7M	17.5M	15.7M	13.8M	11.4M	6M	8.4M	6.2M	4M	0.0	0.0	0.0
Deferred Revenue	0.0	12.1M	13.9M	20.9M	19.6M	16M	13.9M	15.1M	17M	21.5M	17.6M	15.7M	16.1M	15.6M	10.1M	11.8M	7.4M	6.6M	4.3M	3.9M
Other Current Liabilities	97.3M	-4.7M	73.8M	82.7M	83M	85.4M	69M	35.7M	28.7M	23.7M	27.7M	23.2M	40.8M	42.2M	22M	35.2M	25.9M	30.2M	19.8M	12.9M
Total Current Liabilities	128.6M	139.6M	118.8M	143.8M	160.8M	168.1M	136.1M	148.7M	141.2M	138.5M	131.4M	108.7M	95.9M	70.8M	59.7M	57.6M	40.5M	54.5M	40.2M	39.8M
NON-CURRENT LIABILITIES
Long Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7M	35M	28M	0.0
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	-17.3M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Tax Liabilities (Non-Current)	4.9M	4.1M	4.6M	4.1M	7.5M	12M	10.3M	13.4M	13.7M	5.5M	9.8M	10.6M	10.9M	10M	9.9M	0.0	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	23.2M	8M	7M	7.3M	4.1M	6.3M	18.8M	1.3M	1.1M	1.4M	1.2M	1.1M	1.2M	938K	942K	1M	1.6M	1.2M	2.3M	0.0
Total Non-Current Liabilities	28.1M	22.2M	16.7M	18.2M	21.8M	31.2M	29.1M	14.6M	14.9M	6.9M	11M	11.7M	12.1M	10.9M	10.9M	1M	8.6M	36.2M	30.3M	0.0
Capital Lease Obligations	0.0	16.2M	12.4M	6.9M	10.2M	12.9M	8.3M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	156.6M	161.9M	135.6M	162.1M	182.6M	199.2M	165.2M	163.3M	156.1M	145.4M	142.4M	120.4M	107.9M	81.8M	70.6M	58.6M	49.1M	90.7M	70.5M	39.8M
SHAREHOLDERS' EQUITY
Common Stock	18K	19K	19K	19K	19K	21K	22K	24K	24K	24K	13K	13K	14K	14K	15K	16K	15K	15K	16K	18K
Additional Paid-In Capital	0.0	75.8M	65.7M	55.6M	50M	62.5M	59.4M	72M	76.5M	71.5M	69.7M	61.6M	54.7M	43.8M	49.3M	51.2M	16.4M	8.1M	7.5M	15.6M
Retained Earnings	465.7M	478.9M	445.2M	391.6M	344.6M	382.8M	306.1M	329.5M	288.1M	265.4M	214.9M	166.4M	200M	134.8M	118.8M	90.2M	56.4M	24.1M	30.1M	44.3M
Accumulated Other Comprehensive Income/Loss	-16.2M	-22.7M	-13.7M	-12.8M	458K	-3.6M	-13.9M	-10.4M	-1.4M	-11.6M	-3.8M	2.1M	5.8M	6.9M	5.8M	3.7M	1.5M	-375K	989K	355K
Other Total Stockholders' Equity	83.5M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Stockholders' Equity	533.1M	532.1M	497.2M	434.5M	395.1M	441.7M	351.7M	391.1M	363.2M	325.3M	280.9M	230.2M	260.5M	185.6M	173.9M	145.2M	74.4M	31.8M	38.6M	60.2M
Total Equity	586.3M	586.3M	497.2M	434.5M	395.1M	441.7M	351.7M	391.1M	363.2M	325.3M	280.9M	230.2M	260.5M	185.6M	173.9M	145.2M	74.4M	31.8M	38.6M	60.2M
Minority Interest	53.2M	54.2M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SUMMARY
Total Liabilities & Equity	742.9M	748.2M	632.8M	596.5M	577.7M	640.9M	516.9M	554.5M	519.3M	470.6M	423.2M	350.6M	368.5M	267.4M	244.5M	203.8M	123.4M	122.6M	109.1M	100M
Total Investments	0.0	2.7M	2.8M	2.9M	23.8M	3.1M	2.9M	63.5M	9.8M	9.7M	11.4M	0.0	8.6M	0.0	0.0	-1.7M	-2.1M	-2.9M	-2M	-2.2M
Total Debt	14M	39.2M	13.2M	13.8M	17.3M	21.5M	8.3M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7M	35M	28M	0.0
Net Debt	-144.4M	-142.6M	-317.2M	-274.6M	-222.5M	-291.4M	-226.5M	-214.3M	-247.1M	-175.8M	-143.2M	-111.1M	-137.3M	-70.8M	-50.4M	-24.2M	-6.7M	21.7M	15.1M	-27M
Shares Outstanding	18,271,836	18,271,836	18,271,836	18,271,836	18,271,836	18,271,836	18,271,836	18,271,836	18,271,836	18,271,836	18,271,836	18,271,836	18,271,836	18,271,836	18,271,836	18,271,836	18,271,836	18,271,836	18,271,836	18,271,836

SEC Filings

USNA - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 20, 2026	May 20, 2026	2026	View Filing
10-Q 10-Q 2026 Q2 Q2	May 12, 2026	April 04, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 05, 2026	May 05, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 07, 2026	January 03, 2026	2026	View Filing
10-K 10-K 2026 FY FY	March 16, 2026	January 03, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 18, 2026	February 17, 2026	2026	View Filing
8-K/A 8-K/A 2026 (Amended) N/A	February 11, 2026	February 11, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 12, 2026	January 12, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 08, 2026	January 08, 2026	2026	View Filing
10-Q 10-Q 2025 Q3 Q3	November 05, 2025	September 27, 2025	2025	View Filing

Showing 1 to 10 of 363 filings

Related Guides

Blog Categories

Continue your USNA research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.